International Journal of Experimental Dental Science

Register      Login

VOLUME 4 , ISSUE 1 ( January-June, 2015 ) > List of Articles

RESEARCH ARTICLE

Localized Gingival Enlargement induced by Systemic Administration of Phenytoin for the Management of Epidermolysis Bullosa

K Smitha Gowda, Shilpa Vinod

Citation Information : Gowda KS, Vinod S. Localized Gingival Enlargement induced by Systemic Administration of Phenytoin for the Management of Epidermolysis Bullosa. Int J Experiment Dent Sci 2015; 4 (1):58-61.

DOI: 10.5005/jp-journals-10029-1096

License: CC BY-SA 3.0

Published Online: 00-06-2015

Copyright Statement:  Copyright © 2015; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

How to cite this article

Gowda KS, Vinod S. Localized Gingival Enlargement induced by Systemic Administration of Phenytoin for the Management of Epidermolysis Bullosa. Int J Experiment Dent Sci 2015;4(1):58-61.


PDF Share
  1. The classification of inherited epidermolysis bullosa (EB): report of the Third International Consensus Meeting on Diagnosis and Classification of EB. J Am Acad Dermatol 2008;58:931-950.
  2. Management of the oral surgery patient diagnosed with epidermolysis bullosa: report of 3 cases and review of the literature. J Oral Maxillofac Surg 2008 Mar;66(3):554-559.
  3. Orthodontic treatment of a patient with recessive dystrophic epidermolysis bullosa: a case report. Spec Care Dentist 2008;28(4):136-139.
  4. Dental and anesthetic management of a child with epidermolysis bullosa. J Ind Soc Pedod Prev Dent 2011;29(2):155-160.
  5. Epidermolysis bullosa. HU Rev 2000;26:221-227.
  6. Phenytoin therapy of recessive dystrophic epidermolysis bullosa—clinical trial and proposed mechanism of action on collagenase. N Engl J Med 1980 Oct;303:776-781.
  7. A hereditary epidermolysis bullosa: oral manifestations and dental therapy. Oral Surg Oral Med Oral Pathol 1976 Oct;42(4):490-500.
  8. Oral manifestations of epidermolysis bullosa. In: Fine JD, Bauer EA, McGuire J, Moshell A, editors. Epidermolysis bullosa: clinical, epidemiologic and laboratory advances and the findings of the National Epidermolysis Bullosa Registry. Baltimore: Johns Hopkins University Press. 1999. p. 236-257.
  9. Oral healthcare for patients with epidermolysis bullosa—best clinical practice guidelines. Int J Paediat Dentist 2012;22(Suppl 1):1-35.
  10. Phenytoin in cutaneous medicine: its uses, mechanisms and side effects. Dermatol Online J 2003 Aug;9(3):6.
  11. Epidermolysis bullosa in the eastern province of Saudi Arabia. Int J Dermatol 1993 Aug;32(8):579-581.
  12. Epidermolysis bullosa: report of one case. Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi 1990 Nov-Dec;31(6):383-387.
  13. Dystrophic epidermolysis bullosa inversa. Dermatologica 1990;181(2):145-148.
  14. Therapeutic efficacy of phenytoin inrecessive dystrophic epidermolysis: a comparison of shortand long-term treatment. Arch Dermatol 1984 Apr;120(4):490-495.
  15. Development defects of enamel in humans with hereditary epidermolysis bullosa. Arch Oral Biol 1993 Nov;38(11):945-955.
  16. Epidermolysis bullosa associated with enamel hypoplasia and taurodontism. J Oral Pathology 1983;12(2):73-83.
  17. Oral manifestations in the epidermolysis bullosa spectrum. Dermatol Clin 2010;28(1):159-164.
  18. Epidermolysis bullosa and dental developmental age. Int J Paediatr Dent 2005 Sep;15(5):335-341.
  19. Dental and anaesthetic management of children with dystrophic epidermolysis bullosa. Int J Paediatr Dent 2009 Mar;19(2):127-134.
  20. Dental caries risk in hereditary epidermolysis bullosa. Pediatr Dent 1994;16(6):427-432.
  21. Ozone therapy in dentistry: a strategic review. J Nat Sc Biol Med 2011;2(2):151-153.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.